MGC Diagnostics (MGCD) Swings to Q4 Loss

MGC Diagnostics (NASDAQ: MGCD) reported Q4 EPS of ($0.07), versus $0.20 reported last year. Revenue for the quarter came in at $9.7 million, versus $9.14 million reported last year.

For earnings history and earnings-related data on MGC Diagnostics (MGCD) click here.

You May Also Be Interested In

• Coherent posts a blowout Q4 and aggressive guidance, yet shares take a 5% haircut
• Spire Global (SPIR) Tops Q2 EPS by 2c; Offers Guidance
• A2Z Cust2Mate (AZ) Misses Q2 EPS by 1c